tradingkey.logo

Bayer Says U.S. FDA Approves Finerenone

ReutersJul 14, 2025 6:37 AM

- BAYER AG BAYGn.DE:

  • U.S. FDA APPROVES FINERENONE FOR NEW INDICATION IN PATIENTS WITH HEART FAILURE WITH LEFT VENTRICULAR EJECTION FRACTION OF ≥ 40%

  • FURTHER REGULATORY APPLICATIONS TO HEALTH AUTHORITIES IN OTHER MARKETS WORLDWIDE HAVE BEEN FILED OR WILL FOLLOW

Further company coverage: [BAYGn.DE]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI